Dose adjustment and supportive care before and during treatment

Cancer Treatment Reviews

Volumn 35, Issue 6, 2009, Pages 493-498

  Brunello, Antonella ^a   Loaldi, Elena ^b   Balducci, Lodovico ^c  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chemotherapy; Comorbidity; Elderly; Growth factors; Pain management; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DOXORUBICIN; DRUG METABOLITE; ERYTHROPOIETIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; NAVELBINE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXALIPLATIN; PEMETREXED; PLATINUM COMPLEX; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TAXANE DERIVATIVE; UNINDEXED DRUG; VINCRISTINE;

ADJUVANT THERAPY; ANEMIA; BLADDER CANCER; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CAREGIVER; CLINICAL TRIAL; COLORECTAL CANCER; COMORBIDITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; ELDERLY CARE; FEBRILE NEUTROPENIA; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; NEUROTOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY CANCER; PATIENT CARE; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PRESCRIPTION; REVIEW; SOCIAL SUPPORT;

AGED; AGING; ANEMIA; ANTINEOPLASTIC AGENTS; CAREGIVERS; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; NEOPLASMS; PAIN, INTRACTABLE;

EID: 70349329498     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2009.04.009     Document Type: Review

References (60)

1. Lichtman S.M., Balducci L., and Aapro M. Geriatric oncology: a field coming of age. J Clin Oncol 25 14 (2007) 1821-1823
2. Lewis J.H., Kilgore M.L., Goldman D.P., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21 (2003) 1383-1389
3. Lichtman S.M., Wildiers H., Chatelut E., et al. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients - an analysis of the medical literature. J Clin Oncol 25 14 (2007) 1832-1843
4. Kumar A., Soares H.P., Balducci L., and Djulbegovic B. Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol 25 10 (2007) 1272-1276
5. Balducci L. Aging, frailty, and chemotherapy. Cancer Control 14 1 (2007) 7-12
6. Rockwood K., Rockwood M.R., Andrew M.K., and Mitnitski A. Reliability of the hierarchical assessment of balance and mobility in frail older adults. J Am Geriatr Soc 56 7 (2008) 1213-1217
7. Carreca I., Balducci L., and Extermann M. Cancer in the older person. Cancer Treat Rev 31 5 (2005) 380-402
8. Zinzani P.L., Storti S., Zaccaria A., et al. Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood 94 1 (1999) 33-38
9. Gridelli C., Maione P., Illiano A., et al. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. J Clin Oncol 25 29 (2007) 4663-4669
10. Pepe C., Hasan B., Winton T.L., et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 25 12 (2007) 1553-1561
11. NCCN Practice Guidelines in Oncology v.2.2007 at [accessed 23.01.09].
12. Fulton M.M., and Allen E.R. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 17 (2005) 123-132
13. Popa M., Wallace K., Brunello A., and Extermann M. The impact of polypharmacy on toxicity from chemotherapy in elderly patients: focus on cytochrome P-450 inhibition and protein binding effects. Proc Am Soc Clin Oncol 2008, J Clin Oncol 26 (2008) (May 20 Suppl; abstr. 9505)
14. Lichtman S.M., and Boparai M.K. Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy. Curr Treat Options Oncol (2008) [Epub ahead of print]
15. Lichtman S.M., Wildiers H., Launay-Vacher V., et al. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 43 1 (2007) 14-34
16. Wildiers H. Mastering chemotherapy dose reduction in elderly cancer patients. Eur J Cancer 43 (2007) 2235-2241
17. Basso U., Tonti S., Bassi C., et al. Management of frail and not-frail elderly cancer patients in a hospital-based geriatric oncology program. Crit Rev Oncol Hematol 66 2 (2008) 163-170
18. Yates J., and Van Zant G. Stem cell exhaustion and aging. In: Balducci L., Ershler W., and De Gaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University Press
19. Bonadonna G., Valagussa P., Moliterni A., et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332 (1995) 901-906
20. De Vita Jr V.V., Hubbard S.M., and Longo D.L. The chemotherapy of lymphomas: looking back moving forward - the Richard, Hinda Rosenthal Foundation award lecture. Cancer Res 47 (1987) 1987-5824
21. Lyman G.H., Kuderer N., Greene J., et al. The economics of febrile neutropenia: implications for the use of colony-stimulating factors. Eur J Cancer 34 (1998) 1857-1864
22. Lyman G.H., Dale D.C., and Crawford J. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices. J Clin Oncol 21 (2003) 4524-4531
23. Lyman G.H., Dale D.C., Friedberg J., et al. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. J Clin Oncol 22 (2004) 4302-4311
24. Muss H.B., Woolf S., Berry D., et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293 (2005) 1073-1081
25. Kwak L.W., Halpern J., Olshen R.A., et al. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol 8 (1990) 963-977
26. NCCN Practice Guidelines in Oncology V.1.2009. [accessed 23.01.09].
27. Smith TJ, Khatcheressian J, Lyman GH, et al. American Society of Clinical Oncology 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline [accessed 23.01.09].
28. Kuderer N.M., Dale D.C., Crawford J., and Lyman G.H. Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25 21 (2007) 3158-3167
29. Vogel C.L., Wojtukiewicz M.Z., Carroll R.R., et al. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23 (2005) 1178-1184
30. Balducci L., Al-Halawani H., Charu V., et al. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 12 12 (2007) 1416-1424
31. Balducci L., Ershler W.B., and Bennett J.M. Anemia in the elderly (2008), Springer, London
32. Ferrucci L., Guralnik J.M., Woodman R.C., et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118 11 (2005) 1288
33. Ganz T., Olbina G., Girelli D., et al. Immunoassay for human serum hepcidin. Blood 112 10 (2008) 4292-4297
34. Ferrucci L., Guralnik J.M., Bandinelli S., et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 136 6 (2007) 849-855
35. Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299 8 (2008) 914-924
36. Luciani A., Jacobsen P.B., Extermann M., et al. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol 31 5 (2008 Oct) 424-430
37. Balducci L. Cancer chemotherapy in the older person. In: Balducci L., Ershler W.B., and DeGaetano G. (Eds). Blood disorders in the elderly (2008), Cambridge University Press, Cambridge, MA 225-255
38. Cova D., and Balducci L. Cancer chemotherapy in the older person. In: Balducci L., Lyman G.H., Ershler W.H., and Extermann M. (Eds). Comprehensive geriatric oncology (2004), Taylor & Francis Publishers 463-490
39. Jacobson S.D., Cha S., Sargent D.J., et al. Tolerability, dose intensity and benefit of 5FU based chemotherapy for advanced colorectal cancer (CRC) in the elderly: a North Central Cancer Treatment Group study. Proc Am Soc Clin Oncol 20 (2001) 384a Abstract #1534
40. Balducci L. Supportive care of elderly patients with cancer. Support Cancer Ther 2 4 (2005) 225-228
41. Deshpande A.D., Harris-Hayes M., and Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther (2008) [Epub ahead of print]
42. Brunello A., Basso U., Rossi E., et al. Ifosfamide-related encephalopathy in elderly patients: report of five cases and review of the literature. Drugs Aging 24 11 (2007) 967-973
43. Patt D.A., Duan Z., Fang S., et al. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 25 25 (2007) 3871-3876
44. Bird B.R., and Swain S.M. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res 14 1 (2008) 14-24
45. Hequet O., Le Q.H., Moullet I., et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol 22 10 (2004) 1864-1871
46. Pinder M.C., Duan Z., Goodwin J.S., et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25 25 (2007) 3808-3815
47. Doyle J.J., Neugut A.I., Jacobson J.S., et al. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol 23 34 (2005) 8597-8605
48. Seidman A., Hudis C., Pierri M.K., et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20 5 (2002) 1215-1221
49. Bengala C., Zamagni C., Pedrazzoli P., et al. Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. Br J Cancer 94 7 (2006) 1016-1020
50. Davis M.P., and Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging 20 (2003) 23-57
51. Kewman D.G., Vaishampayan N., Zald D., and Han B. Cognitive impairment in musculoskeletal pain patients. Int J Psychiatry Med 21 (1991) 253-262
52. Lamberg L. Chronic pain linked with poor sleep: exploration of causes and treatment. JAMA 281 (1999) 691-692
53. Pautex S., Michon A., Guedira M., et al. Pain in severe dementia: self-assessment or observational scales?. J Am Geriatr Soc 54 7 (2006) 1040-1045
54. Gloth III F.M. Pain management in older adults: prevention and treatment. J Am Geriatr Soc 49 (2001) 188-199
55. Pergolizzi J., Böger R.H., Budd K., et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8 4 (2008) 287-313
56. Thomas J., Karver S., Cooney G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358 22 (2008) 2332-2343
57. Smith T.J., Staats P.S., Deer T., et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and serviva. J Clin Oncol 20 19 (2002) 4040-4049
58. Lyness J.M., Noel T.K., Cox C., et al. Screening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies - Depression Scale and the Geriatric Depression Scale. Arch Intern Med 157 (1997) 449-454
59. Haley W.E. Family caregivers of elderly patients with cancer: understanding and minimizing the burden of care. J Support Oncol 1 Suppl. 2 (2003) 25-29
60. Monfardini S., Gridelli C., Pasetto L.M., et al. Vulnerable and frail elderly: an approach to the management of the main tumour types. Eur J Cancer 44 4 (2008) 488-493